OTC Pharmaceuticals - Togo | Statista Market Forecast

Revenue in the OTC Pharmaceuticals market amounts to US$33.93m in 2024. The market is expected to grow annually by 9.17% (CAGR 2024-2029).
The market's largest segment is the segment Skin Treatment with a market volume of US$9.53m in 2024.
In global comparison, most revenue is generated United States (US$41bn in 2024).
In relation to total population figures, per person revenues of US$3.66 are generated in 2024.
In the OTC Pharmaceuticals market, 6.8% of total revenue will be generated through online sales by 2024.

Definition:
The Over-the-Counter Pharmaceuticals market includes non-prescription medications, treatments, and healthcare products that are available directly to consumers without a prescription from a licensed healthcare professional. It includes both products which are exclusively sold in pharmacies and products which can be purchased elsewhere such as supermarkets, and online retailers. Sales by hospitals are not included.

Structure:
The market is subdivided into Analgesics, Cold and Cough Remedies, Digestives and Intestinal Remedies, Skin Treatment, Vitamins and Minerals, Hand Sanitizer, Eye care, Sleep aids, Wound care, and Other OTC Pharmaceuticals. The Analgesics market covers non-prescription pain-relief medications which help to relief aches, pains and fevers. Cold & Cough market covers non-prescription remedies aimed at relieving nasal congestion, coughing, sore throat, and related cold discomforts. The Digestives and Intestinal Remedies market encompasses non-prescription products designed to alleviate symptoms related to digestive discomfort and intestinal issues. The Skin Treatment market includes non-prescription medications formulated to address various dermatological concerns such as acne, eczema and dryness. The Vitamins and Minerals market comprises non-prescription dietary supplements containing essential nutrients such as vitamins and minerals. The Hand sanitizer market covers sanitizing products which are applied on hands to effectively reduce the presence of bacteria and viruses. The Eye Care market covers non-prescription products to address common eye-related discomforts such as dryness, irritation or redness. The Sleep Aids market covers non-prescription products designed to promote relaxation, alleviate insomnia, and improve sleep quality. The Wound Care market includes non-prescription products designed to facilitate wound healing and prevent infection.

Additional information:
OTC Pharmaceuticals comprises revenues, average revenue per capita. Sales channels show online and offline revenue. Revenues include VAT. The market only displays B2C revenues, hence B2B and B2G revenues are not included.
For more information on the data displayed, use the info button next to the boxes.

Natural and synthetic agents
Analgesics (e.g. Asprin, Paracetamol)
Cough & Cold remedies (e.g. Vicks VapoRub)
Vitamins and Minerals
Skin treatment products

Prescription medicines
Homeopathic remedies

The OTC Pharmaceuticals market in Togo has been experiencing significant growth in recent years. Customer preferences, trends in the market, local special circumstances, and underlying macroeconomic factors have all contributed to this development.

Customer preferences in Togo have shifted towards self-medication and a preference for over-the-counter (OTC) pharmaceutical products. This can be attributed to a growing awareness of health and wellness, as well as an increasing desire for convenience and accessibility. Customers are now seeking quick and effective remedies for common ailments, such as headaches, colds, and allergies, which can be easily obtained without a prescription.

Trends in the market reflect the changing customer preferences. The availability of a wide range of OTC pharmaceutical products in pharmacies and drugstores has increased, providing customers with a greater variety of options. Additionally, there has been an increase in the number of pharmacies and drugstores in Togo, further improving accessibility to OTC products.

This expansion of distribution channels has been driven by both local and international pharmaceutical companies, recognizing the potential for growth in the market. Local special circumstances in Togo have also played a role in the development of the OTC Pharmaceuticals market. The country has a relatively underdeveloped healthcare infrastructure, with limited access to healthcare facilities and medical professionals, particularly in rural areas.

This has led to an increased reliance on self-medication and OTC pharmaceutical products as a primary form of healthcare. Furthermore, the affordability of OTC products compared to prescription medications has made them a more attractive option for many Togolese consumers. Underlying macroeconomic factors have also contributed to the growth of the OTC Pharmaceuticals market in Togo.

The country has experienced steady economic growth in recent years, resulting in an increase in disposable income and consumer spending. This has allowed more individuals to afford OTC pharmaceutical products and has contributed to the overall growth of the market. Additionally, the government of Togo has implemented policies to promote the development of the healthcare sector, including the improvement of healthcare infrastructure and the regulation of pharmaceutical products.

These initiatives have created a favorable environment for the growth of the OTC Pharmaceuticals market. In conclusion, the OTC Pharmaceuticals market in Togo is developing due to changing customer preferences, trends in the market, local special circumstances, and underlying macroeconomic factors. The shift towards self-medication, the availability of a wide range of OTC products, limited access to healthcare facilities, and steady economic growth have all contributed to the growth of the market.

As these factors continue to evolve, the OTC Pharmaceuticals market in Togo is expected to further expand in the coming years.

Data coverage:

Data encompasses B2C spend. Figures are based on the OTC Pharmaceuticals market values, representing revenues generated by both product sales which take place exclusively in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use data from national statistical offices, international institutions, trade associations, and self-medication associations. Next, we use relevant key market indicators and data from country-specific associations, such as consumer healthcare spending, out-of-pocket healthcare expenditure, health system accessibilities, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. Whereas this market covers only OTC drugs, the Statista Pharmaceuticals market covers both OTC and prescription drugs.

This report presents a comprehensive analysis and additional information on the Consumer market, in a PDF format.

The global pharmaceutical industry has experienced significant growth during the past two decades, with revenues totaling around 1.6 trillion U.S. dollars in 2023. With growth like that, the industry's size is now comparable to the gross domestic products (GDPs) of countries like Spain, Mexico, or Australia.